|国家科技期刊平台
首页|期刊导航|临床医学工程|高血压性脑出血患者微创颅内血肿清除术后发生再出血的影响因素分析

高血压性脑出血患者微创颅内血肿清除术后发生再出血的影响因素分析OA

Analysis on the Influencing Factors of Rebleeding After Minimally Invasive Intracranial Hematoma Removal in Patients with Hypertensive Intracerebral Hemorrhage

中文摘要英文摘要

目的 分析高血压性脑出血(HICH)患者微创颅内血肿清除术后发生再出血的相关影响因素.方法 回顾性分析 80例行微创颅内血肿清除术的HICH患者的临床资料,统计再出血发生率,采用单因素和多因素分析探讨术后再出血的危险因素.结果 80 例HICH患者术后再出血发生率为 16.25%.单因素和多因素Logistic回归分析显示,术前舒张压>120 mm Hg、术前收缩压>200 mm Hg、术前GCS评分≤8 分、合并糖尿病、术前血肿量≥60 mL是HICH患者微创颅内血肿清除术后发生再出血的独立危险因素(P<0.05).结论 术前舒张压>120 mm Hg、术前收缩压>200 mm Hg、术前GCS评分≤8 分、合并糖尿病、术前血肿量≥60 mL是HICH患者微创颅内血肿清除术后发生再出血的独立危险因素.

Objective To analyze the related influencing factors of rebleeding after minimally invasive intracranial hematoma removal in patients with hypertensive intracerebral hemorrhage(HICH).Methods The clinical data of 80 HICH patients who underwent minimally invasive intracranial hematoma removal were retrospectively analyzed.The rebleeding rate was counted,and the risk factors of postoperative rebleeding were analyzed by univariate analysis and multivariate analysis.Results The incidence of postoperative rebleeding in 80 HICH patients was 16.25%.Univariate analysis and multivariate Logistic regression analysis showed that preoperative diastolic blood pressure>120 mm Hg,preoperative systolic blood pressure>200 mm Hg,preoperative GCS score≤8 points,diabetes mellitus,preoperative hematoma volume≥60 mL were independent risk factors for the occurrence of rebleeding after minimally invasive intracranial hematoma removal in HICH patients(P<0.05).Conclusions Preoperative diastolic blood pressure>120 mm Hg,preoperative systolic blood pressure>200 mm Hg,preoperative GCS score≤8 points,diabetes mellitus,preoperative hematoma volume≥60 mL are independent risk factors for the occurrence of rebleeding after minimally invasive intracranial hematoma removal in HICH patients.

张灵杰;陈娟娟

河南省项城市中医院神经外科,河南项城 466200

临床医学

高血压性脑出血微创颅内血肿清除术再出血

Hypertensive intracerebral hemorrhageMinimally invasive intracranial hematoma removalRebleeding

《临床医学工程》 2024 (002)

253-254 / 2

10.3969/j.issn.1674-4659.2024.02.0253

评论